CACNG3 and glioma: To confirm this finding and further explore the predictive ability of CACNG3 as a potential biomarker, we performed the receiver operating characteristic curve (ROC) for CACNG3 expression and both mesenchymal and neural molecular subtypes of all grade gliomas.